Muye Xia Selected Research

Antiviral Agents (Antivirals)

2/2023	Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study.
1/2023	Prospective observational study of baloxavir marboxil in adults and adolescents with uncomplicated influenza from China.
1/2021	Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B.
1/2021	Hepatitis B surface antigen kinetics after discontinuation of and retreatment with oral antivirals in non-cirrhotic HBeAg-positive chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muye Xia Research Topics

Disease

11	Chronic Hepatitis B 02/2023 - 02/2017
4	Infections 11/2023 - 06/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2024 - 11/2023
2	Hepatitis B 01/2021 - 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2024
1	Shock 11/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2023
1	Fever (Fevers) 01/2023
1	Human Influenza (Influenza) 01/2023
1	Virus Diseases (Viral Diseases) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 02/2017

Drug/Important Bio-Agent (IBA)

5	Hepatitis B e AntigensIBA 02/2023 - 01/2018
4	Antiviral Agents (Antivirals)IBA 02/2023 - 01/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2017
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
1	LigandsIBA 04/2024
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	obatoclaxIBA 11/2023
1	Alanine Transaminase (SGPT)IBA 02/2023
1	DNA (Deoxyribonucleic Acid)IBA 02/2023
1	NucleotidesIBA 02/2023
1	Oseltamivir (Tamiflu)FDA Link 01/2023
1	baloxavirIBA 01/2023
1	nasIBA 01/2021
1	AntigensIBA 01/2021
1	EnzymesIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Telbivudine FDA Link 06/2017
1	entecavir FDA Link 06/2017
1	InterferonsIBA 06/2017
1	LipidsIBA 02/2017
1	Uric Acid (Urate)IBA 02/2017

Therapy/Procedure

7	Therapeutics 11/2023 - 06/2017
1	Aftercare (After-Treatment) 01/2022
1	Retreatment 01/2021